Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zapata Quantum, Inc.ZPTA · Entity 6486 | Director · CEO and CFO | May 01, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zapata Quantum, Inc.
Report date May 01, 2026 · Filed May 07, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,500,000 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 32,500,000 F1: The shares of restricted stock vest in equal monthly installments over a two-year period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.23 · Expires 2034-05-13 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-01 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance Not disclosed F2: The stock options will become exercisable over four years from March 13, 2024, with 25% vesting on March 1, 2025 and the remainder vesting in equal monthly installments thereafter. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.08 · Expires 2030-10-09 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-01 · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · Balance Not disclosed F4: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to continued service as a director of the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.08 · Expires 2030-10-09 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-01 · row 6
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 6 · Balance Not disclosed F5: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over four years, with the first vesting date to occur on November 9, 2025, subject to continued employment with the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement. |
| Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.04 · Expires 2026-06-12 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-01 · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · Balance Not disclosed F3: The Reporting Person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.04 · Expires 2030-06-12 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-01 · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · Balance Not disclosed F3: The Reporting Person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of restricted stock vest in equal monthly installments over a two-year period.
F2: The stock options will become exercisable over four years from March 13, 2024, with 25% vesting on March 1, 2025 and the remainder vesting in equal monthly installments thereafter.
F3: The Reporting Person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share.
F4: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to continued service as a director of the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement.
F5: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over four years, with the first vesting date to occur on November 9, 2025, subject to continued employment with the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2025 Filed Oct 10, 2025 20:37 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantStock Options (Right to Buy) · Derivative | 5,000,000 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001079973-25-001591 · ownership.xml · derivative · entry 2 Kapur Sumit · CIK 0002024204 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2030-10-09 F2 · derivative.exercise_date: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over four years, with the first vesting date to occur on November 9, 2025, subject to continued employment with the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 20:37 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantStock Options (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001079973-25-001591 · ownership.xml · derivative · entry 1 Kapur Sumit · CIK 0002024204 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-10-09 F1 · derivative.exercise_date: The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to continued service as a director of the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:08 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantCommon Stock | 32,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001079973-25-001037 · ownership.xml · nonDerivative · entry 1 Kapur Sumit · CIK 0002024204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500,000 F1 · security: The shares of restricted stock vest in equal monthly installments over a two-year period. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:08 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | PurchaseWarrant · Derivative | 1,250,000 | Not disclosed Strike: $0.04 | Not disclosed |
DisclosureSEC source: 0001079973-25-001037 · ownership.xml · derivative · entry 3 Kapur Sumit · CIK 0002024204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2030-06-12 F2 · security: The reporting person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. F2 · price: The reporting person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:08 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | PurchaseConvertible Promissory Note · Derivative | Not disclosed | $100,000.00 Strike: $0.04 | $100,000.00 |
DisclosureSEC source: 0001079973-25-001037 · ownership.xml · derivative · entry 2 Kapur Sumit · CIK 0002024204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 2,500,000 shares Expires 2026-06-12 F2 · security: The reporting person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.